CIK 0001021561
- Accelerated filer
NU SKIN ENTERPRISES, INC.
Sign in to watch- Ticker
- NUS
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870565309
- Phone
- +1 801-345-1000
- Business address
- 75 WEST CENTER ST, ATTN: GREGORY BELLISTON, PROVO, UT, 84601
- Former names
- NU SKIN ENTERPRISES INC, NU SKIN ASIA PACIFIC INC, NU SKIN ASIA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-15 | Lawrence Mark H Chief Financial Officer | Shares withheld for taxes | −5,139 | $49.65 | $255K | 42,705 |
| 2022-02-15 | NAPIERSKI RYAN S President and CEO | Shares withheld for taxes | −4,498 | $49.65 | $223K | 91,070 |
| 2022-02-11 | Hatchett Steven Keith Chief Product Officer | Grant or award · Employee Stock Option (Right to Buy) | +10,554 | 21,108 | ||
| 2022-02-11 | Hatchett Steven Keith Chief Product Officer | Grant or award · Employee Stock Option (Right to Buy) | +4,879 | 4,879 | ||
| 2022-02-11 | Thomas James D Chief Accounting Officer | Grant or award · Employee Stock Option (Right to Buy) | +9,002 | 9,002 | ||
| 2022-02-11 | Thomas James D Chief Accounting Officer | Grant or award · Employee Stock Option (Right to Buy) | +2,710 | 2,710 | ||
| 2022-02-11 | Clark Chayce David EVP and General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +4,390 | 4,390 | ||
| 2022-02-11 | Clark Chayce David EVP and General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +1,431 | 1,431 | ||
| 2022-02-11 | Clark Chayce David EVP and General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +3,118 | 3,118 | ||
| 2022-02-11 | CHANG JOSEPH Y Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +33,060 | 66,118 | ||
| 2022-02-11 | CHANG JOSEPH Y Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +10,840 | 10,840 | ||
| 2022-02-11 | Lawrence Mark H Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +46,560 | 93,122 | ||
| 2022-02-11 | Lawrence Mark H Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +14,906 | 14,906 | ||
| 2022-02-11 | NAPIERSKI RYAN S President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +70,540 | 141,080 | ||
| 2022-02-11 | NAPIERSKI RYAN S President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +21,883 | 21,883 | ||
| 2022-01-24 | LIPMAN ANDREW D Director | Sale | −1,000 | $50.50 | $51K | 74,214 |
| 2021-12-08 | WOODBURY EDWINA D Director | Grant or award | +12 | $46.19 | $554 | 13,476 |
| 2021-10-05 | Bettinger Jeffrey Clark SVP, People and Places Officer | Sale | −1,625 | $41.10 | $67K | 16,068 |
| 2021-10-01 | Bettinger Jeffrey Clark SVP, People and Places Officer | Shares withheld for taxes | −1,498 | $41.48 | $62K | 17,693 |
| 2021-09-13 | CHANG JOSEPH Y EVP, Chief Scientific Officer | Exercise or conversion | +16,000 | $30.63 | $490K | 33,942 |
Page 16 of 25 · 487 trades